Latest Product Development News

Rent.com.au has seen option holders exercise over $4 million early, injecting significant growth capital and accelerating its path to profitability.

KMD Brands reported a challenging FY25 with a net loss but has launched a transformative ‘Next Level’ strategy focused on cost reset, product innovation, and digital growth. Early FY26 trading shows promising sales momentum, signaling potential turnaround.

Decidr AI Industries has completed its acquisition of the remaining 49% stake in Decidr.ai, issuing 78.4 million shares to the vendor and appointing founder Paul Chan as co-CEO and Chief Innovation Officer.

Li-S Energy has accelerated its transition from research to manufacturing with a $7.8 million ARENA grant, new commercial partnerships, and plans for a large-scale production facility.

Plenti Group Limited reported a robust half-year performance for 1H26, with a 24% increase in its loan portfolio and a 147% surge in Cash Profit Before Tax, underscoring its growing market presence and operational efficiency.

Catapult Sports Ltd reported a 16.9% revenue increase to US$67.6 million for the half-year ended September 30, 2025, driven by strong subscription growth and key acquisitions. Despite a net loss of US$8.6 million, the company bolstered its cash position and expanded its product suite with AI and remote workflow innovations.

Critica Limited confirms gallium as a valuable by-product within its 1.8 billion tonnes Jupiter rare earth resource, achieving a 63% recovery rate in its existing beneficiation flowsheet without altering project scope.

Wisr Limited has successfully completed a $9.4 million institutional placement and launched a $2 million share purchase plan, aiming to reduce debt and accelerate its path to profitability by the second half of fiscal 2026.

Veganic SKN Ltd has launched legal action against Cancer Council Australia over alleged misleading claims about chemical UV filters in sunscreens, coinciding with recent product recalls and the company’s ambitious growth plans for 2026.

Bio-Gene Technology’s natural insecticide Qcide® has earned organic listing status from the US Organic Materials Review Institute, marking a pivotal step for its entry into the organic pest control market.

ECS Botanics has successfully raised nearly A$2 million through a placement aimed at accelerating its international expansion and product development. The move underscores growing investor confidence in the medicinal cannabis company’s strategic growth plans.

Anteris Technologies Global Corp. reported a $22.2 million loss in Q3 2025 while progressing its DurAVR Transcatheter Heart Valve pivotal trial following key regulatory approvals. The company bolstered its cash position with a $25.2 million private placement post-quarter.